Company

ProPhase Labs, Inc. (PRPH)

Standardized SEC financial data for ProPhase Labs, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000868278 · OTC · Pharmaceutical Preparations.

Gross margin

-2.2%

Operating margin

-570.6%

Net margin

-788.2%

Revenue growth (YoY)

-80.7%

Return on equity

-725.7%

ROIC

-318.6%

Free cash flow

-$18.4M

Debt / equity

0.40×

Ratios for fiscal year 2024, standardized from SEC filings.

Income statement

USD	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$9.9M	$14.5M	$79.0M	$122.6M	$35.0M	$6.8M
Cost of revenue	$7.3M	$9.9M	$37.1M	$52.0M	$19.4M	$6.9M
Gross profit	$2.6M	$4.6M	$42.0M	$70.7M

Balance sheet

USD	FY2021	FY2022	FY2022	FY2022	FY2023	FY2024
Cash & equivalents	$8.7M	—	—	$9.1M	$5.3M	$700K
Inventory	$5.0M	—	—	$4.5M	$2.5M	$1.2M
Total current assets	$61.3M	—	—	$60.8M	$47.6M

Cash flow

USD	FY2022	FY2022	FY2022	FY2022	FY2023	FY2024
Operating cash flow	—	—	—	$28.6M	-$12.2M	-$17.5M
Capital expenditures	—	—	—	$3.9M	$2.1M	$906K
Free cash flow	—	—	—	$24.6M	-$14.3M

Get PRPH data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PRPH/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PRPH/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View PRPH filings on SEC EDGAR →